174 related articles for article (PubMed ID: 36789593)
21. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
[TBL] [Abstract][Full Text] [Related]
22. [Impact of prolonging dual antiplatelet therapy on long-term prognosis of elderly patients with coronary heart disease complicated with diabetes mellitus undergoing drug-eluting stent implantation].
Xu JJ; Zhu P; Song Y; Yuan DS; Jia SD; Zhao XY; Yao Y; Jiang L; Xu N; Li JX; Zhang Y; Song L; Gao LJ; Chen JL; Qiao SB; Yang YJ; Xu B; Gao RL; Yuan JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 May; 50(5):450-457. PubMed ID: 35589593
[No Abstract] [Full Text] [Related]
23. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
[No Abstract] [Full Text] [Related]
24. Impact of high-sensitivity C-reactive protein on coronary artery disease severity and outcomes in patients undergoing percutaneous coronary intervention.
Liu Y; Jia SD; Yao Y; Tang XF; Xu N; Jiang L; Gao Z; Chen J; Yang YJ; Gao RL; Xu B; Yuan JQ
J Cardiol; 2020 Jan; 75(1):60-65. PubMed ID: 31416781
[TBL] [Abstract][Full Text] [Related]
25. SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in the FREEDOM Trial.
Esper RB; Farkouh ME; Ribeiro EE; Hueb W; Domanski M; Hamza TH; Siami FS; Godoy LC; Mathew V; French J; Fuster V
J Am Coll Cardiol; 2018 Dec; 72(23 Pt A):2826-2837. PubMed ID: 30522646
[TBL] [Abstract][Full Text] [Related]
26. [Effect of ABO blood groups on long-term outcome of stable coronary artery disease after percutaneous coronary intervention].
Jiang P; Song Y; Jiang L; Zhao XY; Yang YJ; Gao RL; Qiao SB; Xu B; Yuan JQ
Zhonghua Yi Xue Za Zhi; 2019 Aug; 99(29):2288-2292. PubMed ID: 31434404
[No Abstract] [Full Text] [Related]
27. Impact of SYNTAX Score on 10-Year Outcomes After Revascularization for Left Main Coronary Artery Disease.
Yoon YH; Ahn JM; Kang DY; Park H; Cho SC; Lee PH; Lee SW; Park SW; Park DW; Park SJ
JACC Cardiovasc Interv; 2020 Feb; 13(3):361-371. PubMed ID: 32029254
[TBL] [Abstract][Full Text] [Related]
28. The impact of successful chronic total occlusion percutaneous coronary intervention on long-term clinical outcomes in real world.
Gong X; Zhou L; Ding X; Chen H; Li H
BMC Cardiovasc Disord; 2021 Apr; 21(1):182. PubMed ID: 33858349
[TBL] [Abstract][Full Text] [Related]
29. [Long-term prognostic value of mean platelet volume in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention].
Jiang P; Song Y; Xu JJ; Ma YL; Tang XF; Yao Y; Wang HH; Yang YJ; Gao RL; Qiao SB; Xu B; Yuan JQ; Zhang Y
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(9):679-684. PubMed ID: 32187911
[No Abstract] [Full Text] [Related]
30. Incidence, Characteristics, Predictors, and Outcomes of Repeat Revascularization After Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: The SYNTAX Trial at 5 Years.
Parasca CA; Head SJ; Milojevic M; Mack MJ; Serruys PW; Morice MC; Mohr FW; Feldman TE; Colombo A; Dawkins KD; Holmes DR; Kappetein PA;
JACC Cardiovasc Interv; 2016 Dec; 9(24):2493-2507. PubMed ID: 28007201
[TBL] [Abstract][Full Text] [Related]
31. Five-year outcomes of percutaneous versus surgical coronary revascularization in patients with diabetes mellitus (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
Am J Cardiol; 2015 Apr; 115(8):1063-72. PubMed ID: 25733384
[TBL] [Abstract][Full Text] [Related]
32. Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Interventions in Patients With Unprotected Left Main Coronary Artery Disease.
Zheng Z; Xu B; Zhang H; Guan C; Xian Y; Zhao Y; Fan H; Yang Y; Wang W; Gao R; Hu S
JACC Cardiovasc Interv; 2016 Jun; 9(11):1102-11. PubMed ID: 27282597
[TBL] [Abstract][Full Text] [Related]
33. Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial.
Farooq V; Serruys PW; Bourantas C; Vranckx P; Diletti R; Garcia Garcia HM; Holmes DR; Kappetein AP; Mack M; Feldman T; Morice MC; Colombo A; Morel MA; de Vries T; van Es GA; Steyerberg EW; Dawkins KD; Mohr FW; James S; Ståhle E
Eur Heart J; 2012 Dec; 33(24):3105-13. PubMed ID: 23103663
[TBL] [Abstract][Full Text] [Related]
34. [Clinical outcomes with beta-blockers in stable patients undergoing percutaneous coronary intervention with adequate left ventricular ejection function].
Chen Y; Song Y; Xu JJ; Tang XF; Wang HH; Jiang P; Jiang L; Liu R; Zhao XY; Gao LJ; Song L; Zhang Y; Chen J; Gao Z; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
Zhonghua Yi Xue Za Zhi; 2018 Dec; 98(45):3666-3671. PubMed ID: 30526776
[No Abstract] [Full Text] [Related]
35. Comparison of Five-Year Outcome of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Triple-Vessel Coronary Artery Disease (from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2).
Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Tazaki J; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
Am J Cardiol; 2015 Jul; 116(1):59-65. PubMed ID: 25956622
[TBL] [Abstract][Full Text] [Related]
36. [Different revascularization strategies for patients with coronary artery disease complicating reduced ejection fraction].
Lyu Y; Liu JH; Wang SP; Zheng Z; Wu Z
Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(26):2071-2076. PubMed ID: 34275241
[No Abstract] [Full Text] [Related]
37. Impact of chronic obstructive pulmonary disease on prognosis after percutaneous coronary intervention and bypass surgery for left main coronary artery disease: an analysis from the EXCEL trial.
Huang X; Redfors B; Chen S; Liu Y; Ben-Yehuda O; Puskas JD; Kandzari DE; Merkely B; Horkay F; van Boven AJ; Boonstra PW; Sabik JF; Serruys PW; Kappetein AP; Stone GW
Eur J Cardiothorac Surg; 2019 Jun; 55(6):1144-1151. PubMed ID: 30596978
[TBL] [Abstract][Full Text] [Related]
38. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
[TBL] [Abstract][Full Text] [Related]
39. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
[TBL] [Abstract][Full Text] [Related]
40. The association between fibrinogen levels and severity of coronary artery disease and long-term prognosis following percutaneous coronary intervention in patients with type 2 diabetes mellitus.
Su H; Cao Y; Chen Q; Ye T; Cui C; Chen X; Yang S; Qi L; Long Y; Xiong S; Cai L
Front Endocrinol (Lausanne); 2023; 14():1287855. PubMed ID: 38093962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
